Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Ventripoint Diagnostics Ltd V.VPT

Sector: Healthcare | Sub-Sector: Medical Instruments & Supplies
Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a medical device company engaged in the development of diagnostic tools that monitor patients with heart disease.
Price: $0.065 Volume: 168,000
Change: $0.00 % Change: 0.00%
Day High/Low: 0.065/0.06 52 Week High/Low: 0.09/0.04
Last Traded: July 27, 2015 11:59 Transaction Volume: 30000
Open: 0.065 Previous Close: 0.065
Bid: 0.065 Ask: 0.07
Bid Size: 22000 Ask Size: 457000
Market Cap: 13.1m Shares Out: 201.4m
PE Ratio: N/A Dividend Yield: N/A


Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Ventripoint Diagnostics (V.NRT) down by over 40%

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   November 18, 2013
0 stars

Latest Bullboard Posts

  • RE:New video?

    0 stars

    Yes fiveniner it does look good, i particulary like the possibilities of the stated use of VMS to " Establish baseline and track patient...

    3 stars

  • RE:New video?

    2.5 stars

    It says the analysis can be done from any laptop/desktop computer or the VMS pullcart. Good news because VMS could dump the cart at some...

    3 stars

  • New video?

    3 stars

    I am not sure when exactly this was posted but google tells me it was 13 hours ago (sometimes this gets a little wonky though) Anyway, I...

    2 stars

  • RE:RE:RE:Ventripoint on Today's Financial Post

    0 stars

    eyentre no this comment from Bodke is not a sly attempt to early release Montefiore study results to tip off investors or anything like...

    2.5 stars

  • RE:RE:Ventripoint on Today's Financial Post

    4 stars

    Bodtke adds that “adding right ventricular volume analysis to a routine echocardiogram on hospital admission may reduce a length of...

    3 stars